Screening Anal HPV Colonization in Men Sex Men Using Pre-exposure Prophylaxis for HIV
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 100
- Locations
- 2
- Primary Endpoint
- typing HPV
Study Overview
Brief Summary
This is an interventional study investigating HPV carriage and liquid-based cytology at anal level. It will be offered to all patients undergoing PreP consultations at Besançon University Hospital. The anal swab will be taken by the doctor using a cyto-brush during the consultation.
Detailed Description
The duration of participation in the study is 3 months for the submission of the results of the samples. A medical proctology consultation may also be offered, depending on the results of the screening.
This will be carried out in addition to the anal swabs taken quarterly to screen for other sexually transmitted infections.
A questionnaire will be completed by the doctor to record the data of interest. From additional data already entered in the e-NADIS software will be included for study.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Men sex Men Using Pre-exposure Prophylaxis for HIV Follow up au CHU de Besançon.
Exclusion Criteria
- •History of HPV related cancer
Arms & Interventions
ANAPreP-HPV
A prelevement for HPV genotyping and anal cytology will be carried out in addition to the anal swabs taken quarterly to screen for other sexually transmitted infections.
A questionnaire will be completed by the doctor to record the data of interest.
Intervention: A prelevement for HPV genotyping and anal cytology will be carried out in addition to the anal swabs taken quarterly to screen for other sexually transmitted infections. (Other)
Outcomes
Primary Outcomes
typing HPV
Time Frame: day 1
typing HPV
prevalence HPV
Time Frame: day 1
prevalence HPV
Secondary Outcomes
- High risk HPV risk factors(day 1)
- Cytologist abnormalies(day 1)